Y-Intercept (HK)
LENZ icon

Y-Intercept (HK)’s LENZ Therapeutics LENZ Stock Holding History

Y-Intercept (HK)’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-70,728
Closed -$402K – 2170
2026
Q2 		$402K Sell
70,728
-87,987
-55% -$709K 0.01% 1373
2026
Q1 		$1.45M Buy
158,715
+118,100
+291% +$1.66M 0.03% 872
2025
Q4 		$650K Buy
+40,615
New +$1.18M 0.01% 1149

Other funds holding LENZ

KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Harbor Capital Advisors
Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Owl Creek Wealth Partners
Owl Creek Wealth Partners Denver, Colorado $355M AUM
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Y-Intercept (HK)'s LENZ Position: Q3 2026 in Review

Y-Intercept (HK) sold out of LENZ Therapeutics (LENZ) in Q3 2026, closing a stake of 70,728 shares — an estimated $402K sold.

Y-Intercept (HK) first reported a position in LENZ in Q4 2025 and held it in 3 quarters. The position peaked at $1.45M in Q1 2026. 13 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Y-Intercept (HK) reported no remaining LENZ Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 70,728 LENZ Therapeutics shares in Q3 2026, an estimated $402K.
  • Y-Intercept (HK) first reported a position in LENZ Therapeutics in Q4 2025 and held it in 3 quarters.
  • Y-Intercept (HK)'s LENZ Therapeutics position peaked at $1.45M in Q1 2026.
  • 13 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.